Variable

With envenomation (n=46), %

Age (years) (mean ± SD)

7.52 ± 0.70

Male gender

27(58.70)

Time of bite (night)

30(65.21)

Residence (Rural)

31(67.40)

Socioeconomic status

Middle

14(30.43)

Lower

32(69.57)

Toilet facility (yes)

36(78.26)

Electric load shedding (yes)

24 (52.17)

Site of bite

Upper limb

17(36.96)

Lower limb

29(63.04)

Primary treatment provider

Medical person

34(73.91)

Paramedical staff

9(19.56)

Village health healer

3(06.52)

Type of primary treatment

Tourniquet application

1(2.17)

ASV

17(36.96)

Tetanus Toxoid

41(89.13)

Primary treatment <1hr of bite

24(52.17)

Primary treatment >1hr of bite

22(47.83)

Admission <6Hrs of bite

25(54.35)

Admission >6Hrs of bite

21(45.65)

Sign and symptoms at admission

Local edema

30(65.20)

Local pain

20(43.48)

Vomiting

30(65.21)

Diplopia

7(15.22)

Altered consciousness

10 (27.74)

Ptosis

5(10.87)

Cellulitis

22(47.83)

Hypotension

6(13.04)

Respiratory paralysis

4(8.70)

Acute renal failure

5(10.87)

Type of envenomation

Predominantly vasculotoxic

26 (56.53)

Predominantly neurotoxic

14(30.43)

Mixed

6(13.04)

Investigation

Admission Hb% (mean ± SD)

10.97 ± 2.68

INR (mean ± SD)

1.15 ± 0.06

Creatinine (mg/dl) (mean ± SD)

0.79 ± 0.21

PT (sec) (mean ± SD)

14.22 ± 0.70

PTTK (sec) (mean ± SD)

26.03 ± 3.53

Outcome

Discharge

37(80.43)

Death

9(19.57)

Hospital stay

Length of stay (days)

1-31

Mean stay (days) (mean ± SD)

11 ± 5.65

Table 1: Baseline characteristics, clinical, laboratory features, treatment and outcome of children with snake envenomation

Variables

Non-survival (n=9)

Survival (n=37)

P Value

Age (mean±SD)

6±3.42

7.89±1.41

0.01

Age ≥5years

5(55.55)

32(86.49)

0.03

Male gender

7(77.78)

20(54.05)

0.39

Primary Treatment provider

Medical person

7(77.78)

27(72.97)

1.00

Paramedical staff

1(11.11)

8(21.62)

0.80

Village Health Healer

1(11.11)

2(5.41)

1.00

Type of primary treatment

Tourniquet application

1(11.11)

00

 

ASV

5 (55.55)

12(32.43)

0.19

Tetanus Toxoid

7(77.78)

34(91.89)

0.19

Primary treatment <1hr of bite

3 (33.33)

21(56.76)

0.20

Primary treatment >1hr of bite

6 (66.67 )

16(43.24)

0.20

Admission <6Hrs of bite

6 (66.67 )

19(51.35)

0.40

Admission >6Hrs of bite

3 (33.33)

18(48.65)

0.40

Local edema

7(77.78)

28(75.67)

0.89

Vomiting

6(66.67)

20(54.05)

0.49

Diplopia

7(77.78)

8(21.62)

0.001

Altered consciousness

9(100)

12(32.43)

<0.001

Ptosis

9(100)

12(32.43)

<0.001

Cellulitis

2(22.22)

29(78.38)

0.001

Hypotension

3(33.33)

3(8.10)

0.04

Respiratory failure

8(88.89)

11(29.73)

0.001

Acute renal failure

3(33.33)

5(13.51)

0.15

Type of envenomation

Predominantly vasculotoxic

4(44.44)

22(59.46)

0.41

Predominantly neurotoxic

3(33.33)

11(29.73)

0.83

Mixed

2(22.22)

4(11.76)

0.36

Investigation

Admission Hb%

10.96 ± 1.10

10.68 ± 2.82

0.77

INR

1.2 ± 0.07

1.2 ± 0.07

1.00

PT (sec)

15.56 ± 2.37

14.68 ± 0.1

0.02

PTTK(sec)

26.22 ± 1.68

26.69 ± 2.82

0.63

Creatinine(mg/dl)

0.95 ± 0.5

0.8 ± 0.14

0.11

Length of stay(days)

1-15

1-31

 

Mean stay (days)

4.43 ± 4.43

5.86 ± 5.13

0.12

ASV- Anti Snake Venom; INR-International Normalized Ratio; PT-Prothrombin time; PTTK- Partially Activated Prothrombin Time
Table 2: Univariate logistic regression of factors affecting outcome in children with systemic envenomation

Variables

Died

Survival

Adjusted OR(95% CI

P value

Age >5 years

5(55.55)

32(86.49)

0.35(0.01-7.11)

0.497

Diplopia

7(77.78)

8(21.62)

2.45(6.12-47.83)

0.553

Hypotension

3(33.33)

03(8.10)

164.58(0.05-119.07)

0.307

Cellulitis

2(22.22)

29(78.38)

0.049(0.00-165.72)

0.468

Prothrombin Time(Sec)

15.56±2.37

14.68±0.1

0.59(0.28-1.23)

0.161

Table 3: Multiple logistic regressions of factors for predictors associated with outcome with snake envenomation.